Home | Stock Market Blogs | Financial Tools | Sign Up Free

Pharmaceuticals Market Industry
More Pages: Page: (1)
NASDAQ:ARXTAdams Respiratory Therapeutics. Inc.
 Adams Respiratory Therapeutics is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter, or OTC, and prescription pharmaceuticals for the treatment of respiratory disorders. Co.'s customers consist of drug wholesalers, retail drug stores, mass merchandisers, and grocery stores in U.S. As of June 30 2007, Co. marketed seven OTC products under its Mucinex brand, including four products under its Mucinex products for children line, two products under its Delsym brand and one product under its Humibid brand.
 Market CapDay's VolumeLast TradeChange
OTC PK:BNHLFBioniche Life Sciences, Inc.
 Market CapDay's VolumeLast TradeChange
 Bionovo, Inc., a pharmaceutical company, engages in the discovery and development of drugs for cancer and women's health.
 Market CapDay's VolumeLast TradeChange
OTC PK:BIOHFBioTech Holdings, Ltd.
 Biotech Holdings, Ltd. engages in the development and distribution of its type II diabetes drug, primarily in Mexico and Latin America. Its type II diabetes drug is known as Diab IITM. Diab IITM enhances the action of insulin, as well as promotes muscle metabolism, corrects diabetes, and reduces the level of certain circulating lipids. Clinically, it improves both the metabolic and symptomatic aspects of Type II diabetes. Biotech markets Diab IITM in China through its Chinese subsidiary. The company has distribution agreements for marketing Diab IITM in Peru, Mexico, Venezuela, Chile, and Argentina. The company received approval for marketing Diab IITM in Peru and is in regulatory review in Mexico.
 Market CapDay's VolumeLast TradeChange
OTCBB:BGTHBridgetech Holdings International, Inc.
 BioGentec Corporation, through its subsidiary, engages in the development and commercialization of consumer medical products and life style/health improvement products. As of September 30, 2003, it was in the development stage. The company’s first product focus is in the fields of immunomodulation, menopause, pinpoint detoxification, and cholesterol reduction. Its initial patented product, Prehistin, is an allergy prevention product that eliminates the over-production of histamines in reaction to airborne allergens. Histamines are the primary cause of allergy symptoms and, since Prehistin reduces the trigger for histamine over-production (immunoglobulin E–IgE), it prevents allergy symptoms.
 Market CapDay's VolumeLast TradeChange
 Market CapDay's VolumeLast TradeChange
OTC PK:ESALYEisai Co Ltd American Depositary Shares
 Market CapDay's VolumeLast TradeChange
OTCBB:GFRPGFR Pharmaceuticals, Inc.
 GFR Pharmaceuticals, Inc. is a full service private label manufacturing facility specializing in the production of natural-source nutritional, herbal, and sports nutrition products.
 Market CapDay's VolumeLast TradeChange
OTC PK:IZYPFInflazyme Pharmaceuticals Ltd
 Market CapDay's VolumeLast TradeChange
 MERCK KGAA operates in the pharmaceutical and chemical business. Its pharmaceutical business comprises ethical products, generic products, and consumer health care products. The company’s chemical business manufactures liquid crystals for displays; effect pigments and specialty chemicals for the technical industry; electronic chemicals for chip manufacture; salts, acids, alkalis, and solvents for chromatography; reagents, chemicals, and processing materials for the pharmaceutical industry. The company also engages in laboratory distribution through VWR International, Inc. As of December 31, 2002, Merck consisted of 204 companies in 53 countries.
 Market CapDay's VolumeLast TradeChange
OTC PK:MLHPMillenia Hope, Inc.
 Millenia Hope, Inc. develops innovative treatments and medication products. It develops and distributes its anti-malarial drug, Malarex®. The company also owns another anti-matarial agent, strychnos mytroides.
 Market CapDay's VolumeLast TradeChange
OTC PK:PLDLFPaladin Labs, Inc.
 Paladin Labs, Inc. operates as a specialty pharmaceutical company that focuses on acquiring or in-licensing urology, endocrinology, and women’s health products in the Canadian market. Its main products Androderm®, a transdermal testosterone patch; Dostinex®, which is used for the treatment of hyperprolactinemia; Estring®, a hormone replacement therapy; and Plan B™, an emergency contraceptive pill. The company’s products under development include GlucaGen, Histrelin Hydrogel, Implant, Circadin, DHEA, and Statex SR.
 Market CapDay's VolumeLast TradeChange
OTC PK:SWTZFSchwarz Pharma AG
 Schwarz Pharma AG engages in the research, development, approval, manufacture, and marketing of a diversified line of pharmaceutical products and services. It focuses on the treatment of diseases in cardiovascular, central nervous system, gastrointestinal, and urological indications. The majority of company’s products are prescription only, and are sold primarily through pharmaceutical wholesalers. It has operations in Europe, U.S., and Asia.
 Market CapDay's VolumeLast TradeChange
OTC PK:STDAFStada Arzneimittel Ag Namen AKT
 STADA Arzneimittel AG engages in the healthcare business, focusing on three core segments: generics, branded products, and special pharmaceuticals market. Its products in the generic market segment include Omeprazol, Naproxen, Amoxicillin, Enatapril, and Ranitidin. STADA’s branded products include Grippostad, Ladival, Magnetrans, kamistad, and Hoggar. Special pharmaceuticals segment consists of Cell Pharm, a subsidiary of the company that offers oncology products in the German and European markets. The company also offers a range of services for patients, doctors, and pharmacists that include patient advisories, informational material for pharmacists and their customers, informational material for the doctor’s office, and an advanced training program for doctors and pharmacists in Germany, France, Italy, the United Kingdom, Spain, the Netherlands, Belgium, Austria, Denmark, Ireland, and Sweden.
 Market CapDay's VolumeLast TradeChange
OTC PK:TGRNFTong Ren Tang Technologies
 Tong Ren Tang Technologies Co., Ltd. engages in the manufacture and sale of Chinese Patent Medicine. Its major products are granules, tablets, and soft capsules. The company’s main products include Ganmao Qingre Granule, Liuwei Dihuang Pill, Niuhuang Jiedu Tablet, and Ganmao Soft Capsule.
 Market CapDay's VolumeLast TradeChange
More Pages: Page: (1)

Investing by Industry or Market Sector employs non-emotional, numbers driven, value-based industry, sector, and country rotation techniques, that, unlike conventional stock picking methods, focuses instead on identifying and capitalizing on theme movements in the well identified industries & market sectors.

Primarily, this active-asset methodology recognizes that advances in financial markets are defined by "themes", or led by asset classes, industries, and countries, with each advance distinguished by specific sector-driven themes. Employing a disciplined research and valuation process these "themes" are identified so that Portfolio's can be created and/or adjusted toward the most attractive sectors.

Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign UpCopyright © 2014
SmallCapWatch, LLC.
Never invest based soley on information from this website or our e-mail and IM alerts